Skip to main content

Table 5 Hemodynamic data

From: Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in rats

 

N

Heart rate (beats/min)

LVSP (mmHg)

LVEDP (mmHg)

+dp/dt(mmHg/sec)

-dp/dt(mmHg/sec)

TAU (msec)

Sham

19

343(41)

124(14)

4.5(1.2)

8626(1830)

9958(2373)

10.2(2.3)

MI

16

335(48)

113(14)

6.1(2.0)*

6768(1465)**

5624(1232)**

13.7(2.2)**

MI+T4

17

393(74)†

127(22)

5.9(1.9)*

8862(2746)†

7058(1987)** †

10.8(2.0)‡

  1. Data presented as means (SD).
  2. LVSP and LVEDP, left ventricular end-systolic and end-diastolic pressure, respectively; +dp/dt and -dp/dt, maximal rate of pressure development and decline, respectively; *, p < 0.05, **, p < 0.01 vs. Sham rats; †, p < 0.05, ‡, p < 0.01 vs. MI rats; ANOVA with Student-Newman-Keuls’ or Dunnett T3’s (Heart rate, LVSP and +dp/dt) Multiple Comparison Test.